Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 10MG | TABLET | Resolved | 2020-03-04 | 2020-04-07 | 107717 |
ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2020-03-18 | 2020-04-13 | 108920 |
APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108927 |
APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108930 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-03-18 | 2020-04-09 | 108946 |
APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2020-03-20 | 2020-04-24 | 109087 |
APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2020-03-27 | 2020-07-06 | 109678 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2020-03-27 | 2020-09-09 | 109686 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Resolved | 2020-04-01 | 2020-06-02 | 110297 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2020-04-01 | 2020-04-13 | 110315 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Resolved | 2020-04-01 | 2020-05-25 | 110329 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2020-04-01 | 2020-04-01 | 110331 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Resolved | 2020-04-01 | 2020-05-25 | 110339 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2020-04-06 | 2020-05-04 | 111060 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2020-04-07 | 2020-05-22 | 111224 |
LORATADINE | 10MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111892 |
APO-CANDESARTAN | 8MG | TABLET | Resolved | 2020-04-13 | 2020-10-19 | 111895 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111909 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-04-13 | 2020-05-04 | 111918 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2020-04-13 | 2020-04-27 | 111921 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 |